When the low supply of dioposable gloves and price constantly increases, how did BQ+ Medical supply 61.2 million PVC gloves for French customers!

When the low supply of dioposable gloves and price constantly increases, how did BQ+ Medical supply 61.2 million PVC gloves for French customers!

Summary

We Customize Precision Infusion Consumables___Serve More Than 300 Global Brands

When the low supply of dioposable gloves and price constantly increases, how did BQ+ Medical supply 61.2 million PVC gloves for French customers!
                             When the low supply of dioposable gloves and price constantly increases,                                      How did BQ+ Medical supply 61.2 million PVC gloves for French customers!
Recently, the number of confirmed coronavirus infections has exceeded 61 million. With the surge of coronavirus infections around the world, the coming winter will only make the situation worse.

This has affected some of BQ's cooperating international brands. What they urgently need are high-quality masks, gloves with certificates to protect their company's operation and meet the needs of local market. When we received customers' feedbacks or requests , BQ spents time trying to find solutions for customers to solve the problems of low supply of gloves and increasing prices. After visiting some glove manufacturers in China and considering self-pruchasing production lines,  finally we found the fastest and most cost-effective way that is, to be an agent of an internationally renowned glove manufacturer, truly report customer the price that the manufacturer offered to BQ, and then negotiate a little service fee with the customer, which not only achieves the medical quality of the product, but also solves the purchase cost. And finally solved the supply and price issues for customer.

Subsequently, French customer ordered 61.2 million PVC gloves  from BQ+ Medical. For BQ, what we want most is to do our best to provide some help, provide the protective materials needed for clients company's operation, protect the customer's market, and ultimately help cooperative company survive the epidemic and continue to cooperate in the IV / infusion consumable business.